RecruitingPhase 1NCT04928677
Rare condition
Simpson-Golabi-Behmel syndrome
10
studies recruiting now
as of 7 Sept 2026
15
studies registered in total
as of 7 Sept 2026
12
countries with a recruiting site
as of 7 Sept 2026
1 Jul 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1 / Phase 2NCT06795022
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
RecruitingPhase 1NCT06427941
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
RecruitingNot applicableNCT07677774
GPC3-Targeted PET/CT in Hepatocellular Carcinoma
RecruitingPhase 1 / Phase 2NCT07500220
Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 10 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Simpson-Golabi-Behmel syndrome study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Simpson-Golabi-Behmel syndrome
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (GPC3, GPC4).
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).